490
Publications
74.7K
Citations
109
H-Index
1986
Active since
Christoph Wanner is an author at Universitätsklinikum Würzburg specializing in medicine, chronic kidney disease, and nephrology.
Top concepts
MedicineChronic Kidney DiseaseNephrologyUrologyHemodialysisCardiovascular DiseaseRenal DiseaseEnd-stage Renal DiseaseDiabetesPublic Health
Publications per year
1986–2025
490
490
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 11.6K citations · Full text
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · European Heart Journal · 2021 · 5.8K citations · Full text
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 4.7K citations · Full text
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text
Rows per page
1–5 of 490